Protracted survival after resection of metastatic uveal melanoma
โ Scribed by Takekazu Aoyama; Michael J. Mastrangelo; David Berd; Faith E. Nathan; Carol L. Shields; Jerry A. Shields; Ernest L. Rosato; Francis E. Rosato; Takami Sato
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 94 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Thirty-one patients with disseminated melanoma or renal cell cancer (RCC) who had a limited relapse or persistent disease after a partial or complete response to interleukin-2 (IL-z)-based immunotherapy underwent resection of progressing tumors or residual sites of disease. There were no surgery-rel
## Background and objectives: Melanoma patients have a 20-27% rate of 5-year survival after surgical resection of pulmonary metastases. we evaluated tumor doubling time (tdt) and other prognostic factors in an attempt to identify candidates for pulmonary metastasectomy. ## Methods: Review of our